Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5862
Source ID: NCT03313960
Associated Drug: Afrezza Plus One Drop
Title: A Randomized Controlled Trial Evaluating One Drop | Premium With Afrezza vs. One Drop | Premium Alone
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: Afrezza plus One Drop | Premium|OTHER: One Drop | Premium
Outcome Measures: Primary: Hemoglobin A1c, 3-month between-group change in A1c assessed by a central lab, 3 months | Secondary: Insulin Device Satisfaction, Within- and between-group change in insulin device satisfaction assessed by the Insulin Device Satisfaction Survey (IDSS), 3 months|Treatment Adherence, Within- and between-group change in treatment adherence assessed by the Adherence to Refills and Medications Scale for Diabetes (ARMS-D) and the Summary of Diabetes Self-care Activities Medications Subscale administered for each oral diabetes medication (SDSCA-MS) and insulin in the regimen (SDSCA-IS)., 3 months|Self-care, Within- and between-group change in self-care assessed by the SDSCA's other subscales, 3 months|Health-related Productivity, Within- and between-group change in health-related productivity assessed by the Work Productivity and Activity Impairment measure (WPAI)., 3 months|Health-related Quality of Life, Within- and between-group change in health-related quality of life assessed by the Centers for Disease Control Health-related Quality of Life-14 (CDC HRQOL-14) and life satisfaction assessed by the Cantril Self-Anchoring Ladder of Life Satisfaction., 3 months
Sponsor/Collaborators: Sponsor: Informed Data Systems, Inc. | Collaborators: Mannkind Corporation
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 400
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2017-10-05
Completion Date: 2019-12-30
Results First Posted:
Last Update Posted: 2019-02-26
Locations: One Drop, New York, New York, 10002, United States
URL: https://clinicaltrials.gov/show/NCT03313960